# Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-safety-and-survival-with-ruxolitinib-in-patients-with-myelofibrosis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Srđan Verstovšek,Ruben A. Mesa,Jason Gotlib,R. S. Levy,Vikas Gupta,John F. DiPersio,John Catalano,Michael W. Deininger,Carole B. Miller,Richard T. Silver,Moshe Talpaz,E. Winton,Jimmie H. Harvey,Murat O. Arcasoy,Elizabeth O. Hexner,Roger M. Lyons,Azra Raza,Kris Vaddi,William Sun,Wei Peng,V. Sandor,Hagop M. Kantarjian,For the COMFORT-I investigators |
| Citations | 331 |
| DOI | 10.3324/haematol.2014.115840 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://haematologica.org/article/download/7340/45453 |
| OpenAlex ID | https://openalex.org/W2161021913 |
| PMID | 25616577 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Wei Peng](https://scholariq.org/researchers/wei-peng/)

## Paper primary topic

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

## Paper topics

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Kruppel-like factors research](https://scholariq.org/topics/kruppel-like-factors-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.